Risk of malignancy assessment of the different cytologic categories in respiratory cytology samples according to the new guidelines of the Papanicolaou Society of Cytopathology

Abstract

AbstractBackgroundCytology is extremely important for diagnosis of lung carcinoma and the Papanicolaou Society of Cytopathology (PSC) had proposed a new classification system for respiratory cytology for better communication between physicians and better patient management. The objective of this study is to analyze our samples in accordance with this classification and to evaluate the diagnostic accuracy of various cytologic techniques and to assess the risk of malignancy.MethodsEight hundred and twenty respiratory cytology specimens (FNA, BAL, washing, brushing, sputum) collected between 2019 and 2022 were classified according to the PSC system and the risk of malignancy was assessed for each category using follow‐up surgical samples. Sensitivity, specificity, and accuracy rates were determined based on a categorial approach, according to a similar study.ResultsThe data of 820 respiratory cytology specimens from 576 patients were analyzed. 2.6% of these were non‐diagnostic, 64.1% were NM, 5% were AC, 0.4% were N‐B‐LG, 4% were SM and 23.9% were ML. The risk of malignancy for each diagnostic category were: 42.8% for non‐diagnostic, 31.2% for NM, 43.9% for AC, 87.9% for SM, 94.3% for ML. Sensitivity and specificity was calculated using only the malignant cases considered as positive tests and was 45.57% and 97.34% respectively.ConclusionOur results correlated with the PSC system, and it was considered useful in clinical practice. However, more studies should be performed to evaluate the usefulness of this system. The ROMs of each category and the impact of different techniques should be further studied.